TickerFacts.

Sigyn Therapeutics, Inc. (SIGY): Shareholders' Equity

Annual figures by period end, from SEC filings.

Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

-$4.46M
As of 2024-12-31
-$5.92M
As of 2025-09-30
$99.4K2014-12-31: $99.4K2015-12-31: -$82.0K2017-12-31: -$2.09M2018-12-31: -$3.72M2019-12-31: -$9102020-12-31: $99.2K2021-12-31: -$264.6K2022-12-31: -$1.90M2023-12-31: -$3.41M2024-12-31: -$4.46M-$4.46M
2014-12-31 Shareholders' Equity (USD) 2024-12-31
Period endedShareholders' EquityChange YoYSource filing
2024-12-31-$4.46Mn/m2025-04-15, Balance as of period end
2023-12-31-$3.41Mn/m2025-04-15, Balance as of period end
2022-12-31-$1.90Mn/m2024-02-20, Balance as of period end
2021-12-31-$264.6Kn/m2023-03-31, Balance as of period end
2020-12-31$99.2Kn/m2022-03-21, Balance as of period end
2019-12-31-$910n/m2021-04-06, Balance as of period end
2018-12-31-$3.72Mn/m2020-03-30, Balance as of period end
2017-12-31-$2.09Mn/a2019-04-01, Balance as of period end
No annual figure between 2015-12-31 and 2017-12-31.
2015-12-31-$82.0Kn/m2016-03-30, Balance as of period end
2014-12-31$99.4Kn/a2016-03-30, Balance as of period end